Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I-III colorectal cancer

被引:9
|
作者
Xie, Hailun [1 ,2 ]
Wei, Lishuang [3 ]
Liu, Mingxiang [1 ,2 ]
Liang, Yanren [1 ,2 ]
Yuan, Guanghui [1 ,2 ]
Gao, Shunhui [1 ,2 ]
Wang, Qiwen [1 ,2 ]
Lin, Xin [2 ,4 ]
Tang, Shuangyi [5 ]
Gan, Jialiang [1 ,2 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China
[2] Guangxi Key Lab Enhanced Recovery Surg Gastrointes, Nanning, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Geriatr Resp Dis Ward, Nanning, Guangxi, Peoples R China
[4] Guangxi Med Univ, Dept Clin Med, Grade 2018, Nanning, Guangxi, Peoples R China
[5] Guangxi Med Univ, Affiliated Hosp 1, Dept Pharm, 6 Shuangyong Rd, Nanning 530021, Guangxi, Peoples R China
关键词
Colorectal cancer; Overall survival; Disease-free survival; Nutrition; Inflammation; INFLAMMATION; COMPLICATIONS;
D O I
10.1186/s12885-022-10405-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To explore the value of preoperative prognostic immune and nutritional index (PINI) in predicting postoperative complications and long-term outcomes in patients with stage I-III colorectal cancer (CRC).Methods: Restricted cubic splines were used to assess the relationship between PINI and survival in patients with CRC. The Kaplan-Meier method and log-rank test were used to plot the survival curves. The Cox proportional hazards model was used to evaluate independent prognostic predictors in patients with CRC. A logistic regression analysis was performed to identify independent predictors of postoperative complications. The least absolute shrinkage and selection operator (LASSO) logistic regression algorithm was used for feature screening.Results: An evident positive dose-response relationship between PINI and survival in patients with CRC was identified. Compared with patients with a high PINI, those with a low PINI had worse disease-free survival (DFS) (47.9% vs. 66.9%, p < 0.001) and overall survival (OS) (49.7% vs. 70.2%, p < 0.001). The Cox proportional hazards model revealed that PINI was independently associated with DFS (hazard ratio [HR], 0.823; 95% confidence interval [CI], 0.754-0.898; p < 0.001) and OS (HR, 0.833; 95% CI, 0.761-0.912; p < 0.001) in patients with CRC. In the logistic regression analysis, PINI was an independent factor affecting postoperative complications in patients with CRC (odds ratio, 0.710; 95%CI: 0.610-0.810, p < 0.001). The LASSO logistic regression algorithm was used to screen for effective prognostic variables. Finally, we constructed PINI-based nomograms to predict postoperative 1-5-year PFS, and OS in patients with CRC.Conclusion: PINI is an effective biomarker for predicting postoperative complications, DFS, and OS in patients with stage I-III CRC.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
    Hailun Xie
    Lishuang Wei
    Mingxiang Liu
    Yanren Liang
    Guanghui Yuan
    Shunhui Gao
    Qiwen Wang
    Xin Lin
    Shuangyi Tang
    Jialiang Gan
    [J]. BMC Cancer, 22
  • [2] Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery
    Kamada, Teppei
    Haruki, Koichiro
    Nakashima, Keigo
    Takahashi, Junji
    Nakaseko, Yuichi
    Suzuki, Norihiko
    Ohdaira, Hironori
    Eto, Ken
    Ikegami, Toru
    Suzuki, Yutaka
    [J]. SURGERY TODAY, 2023, 53 (9) : 1064 - 1072
  • [3] Prognostic Significance of Preoperative Nutritional Assessment in Elderly Patients who Underwent Laparoscopic Gastrectomy for Stage I-III Gastric Cancer
    Uehara, Hideo
    Ota, Mitsuhiko
    Yamamoto, Manabu
    Nakanoko, Tomonori
    Shin, Yuki
    Shiokawa, Keiichi
    Fujimoto, Yoshiaki
    Nakashima, Yuichiro
    Sugiyama, Masahiko
    Onishi, Emi
    Shimagaki, Tomonari
    Mano, Yohei
    Sugimachi, Keishi
    Morita, Masaru
    Toh, Yasushi
    [J]. ANTICANCER RESEARCH, 2023, 43 (02) : 893 - 901
  • [4] The prognostic impact of different immune landscapes in patients with stage I-III colorectal cancer.
    Inthagard, Jitwadee
    McMillan, Donald
    Edwards, Joanne
    Roseweir, Antonia
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 81 - 82
  • [5] Combining prognostic nutritional index (PNI) and controlling nutritional status (CONUT) score as a valuable prognostic factor for overall survival in patients with stage I-III colorectal cancer
    Kim, Harin
    Shin, Dong-Min
    Lee, Jae-Hoon
    Cho, Eun-Suk
    Lee, Hye Sun
    Shin, Su-Jin
    Park, Eun Jung
    Baik, Seung Hyuk
    Lee, Kang Young
    Kang, Jeonghyun
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Ohtani, Hiroshi
    Iseki, Yasuhito
    Ikeya, Tetsuro
    Sugano, Kenji
    Hirakawa, Kosei
    [J]. BMC CANCER, 2015, 15
  • [7] The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer
    Masatsune Shibutani
    Kiyoshi Maeda
    Hisashi Nagahara
    Hiroshi Ohtani
    Yasuhito Iseki
    Tetsuro Ikeya
    Kenji Sugano
    Kosei Hirakawa
    [J]. BMC Cancer, 15
  • [8] The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I-III colorectal cancer
    Xie, Hailun
    Wei, Lishuang
    Liu, Mingxiang
    Liang, Yanren
    Wang, Qiwen
    Tang, Shuangyi
    Gan, Jialiang
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery
    Sato, Shun
    Shimizu, Takayuki
    Ishizuka, Mitsuru
    Suda, Kotaro
    Shibuya, Norisuke
    Hachiya, Hiroyuki
    Iso, Yukihiro
    Takagi, Kazutoshi
    Aoki, Taku
    Kubota, Keiichi
    [J]. SURGERY TODAY, 2022, 52 (08) : 1160 - 1169
  • [10] The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
    Li, Xiangde
    Zhong, Qiulu
    Luo, Danjing
    Du, Qinghua
    Liu, Wenqi
    [J]. PLOS ONE, 2019, 14 (04):